Keywords:
Outcomes, Outcomes analysis, Ultrasound, Musculoskeletal joint, Interventional non-vascular
Authors:
C. Gianneramo1, F. Bruno1, I. Capretti2, M. V. M. Micelli1, S. Mariani1, F. Arrigoni1, L. Zugaro1, A. Barile1, C. Masciocchi1; 1L'Aquila/IT, 2L' Aquila/IT
DOI:
10.26044/ecr2019/C-1326
Aims and objectives
Hip disorders,
in general,
are responsible for the reduced quality of life in terms of pain,
loss of mobility and independence,
and disability [1].
Many disorders affect the hip joint such as rheumatoid arthritis, femoral-acetabular impingement but osteoarthritis (OA) is certainly the most frequent pathology of the hip joint,
particularly in population over 45 years old with a prevalence ranging from 3 to 11% with a greater incidence in female population (8.7% of men and 9.3% of women) [2],[3].
In recent decades,
local infiltrative therapy has been increasingly used,
in particular by using corticosteroids injection,
with good results in terms of pain reduction and improved functionality [4],[5].
In addition to corticosteroids,
hyaluronic acid (HA) and plasma rich platelet (PRP) are currently used: the first one has the purpose to slow down the degenerative process of cartilage at the articular level; the latter is used because it is rich in growth factors that help tissue regeneration [6].
The aim of this study is to assess the efficacy and safety of hip injections in the treatment of osteoarthritis.